A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction

被引:33
作者
Barnes, CS [1 ]
Alexander, KR [1 ]
Fishman, GA [1 ]
机构
[1] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA
关键词
D O I
10.1016/S0161-6420(01)00981-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To characterize a distinctive form of congenital stationary night blindness (CSNB). Design: Observational case report. Participants: A 30-year-old male with a history of night blindness, several members of his family, a patient with "complete" congenital stationary night blindness (CSNB1), and groups of age-similar control subjects. Methods: Rod-system function was evaluated by measuring psychophysical dark-adapted thresholds, by recording dark-adapted electroretinograms (ERGs), and by fundus reflectometry. Cone-system function was evaluated by recording light-adapted ERGs, including those to sawtooth flicker, and by recording light-adapted visually evoked potentials (VEPs) to luminance increments and decrements. Main Outcome Measures: Dark-adapted thresholds, ERGs, rhodopsin double densities, Goldmann visual fields, and VEPs. Results: The patient's visual acuity, visual fields, and color vision were normal. His peripheral dark-adapted thresholds were rod-mediated but elevated by approximately 3 log units above normal. Rhodopsin double density and bleaching recovery were normal. His dark-adapted maximal-flash ERG showed a "negative" waveform, in which the b-wave was more reduced in amplitude than the a-wave, although the a-wave amplitude was also reduced. The rod photoreceptors contributed to the patient's dark-adapted ERGs, as illustrated by the unequal responses to cone-matched stimuli. The patient's cone-mediated thresholds for long-wavelength stimuli were within the normal range. However, his light-adapted brief-flash b-wave was abnormal in amplitude and implicit time. Selective abnormalities of the ON responses of the cone system were apparent in the patient's reduced b-wave amplitude to rapid-on flicker with a normal response to rapid-off flicker, and his prolonged VEP latencies to increments but not to decrements. Conclusions: The overall pattern of findings distinguishes this patient from previously described forms of CSNB. The results suggest that two factors likely contribute to the patient's night blindness: (1) a rod phototransduction defect and (2) a postreceptoral defect. The results also indicate dysfunction within the cone ON pathway. Ophthalmology 2002;109:575-583 (C) 2002 by the American Academy of Ophthalmology.
引用
收藏
页码:575 / 583
页数:9
相关论文
共 48 条
[1]  
al-Jandal N, 1999, HUM MUTAT, V13, P75, DOI 10.1002/(SICI)1098-1004(1999)13:1<75::AID-HUMU9>3.0.CO
[2]  
2-4
[3]  
Alexander KR, 2001, INVEST OPHTH VIS SCI, V42, P453
[4]   Temporal frequency deficits in the electroretinogram of the cone system in X-linked retinoschisis [J].
Alexander, KR ;
Fishman, GA ;
Grover, S .
VISION RESEARCH, 2000, 40 (20) :2861-2868
[5]  
AUERBACH E, 1969, INVEST OPHTH VISUAL, V8, P332
[6]  
Barnes CS, 1998, RETINA-J RET VIT DIS, V18, P531
[7]   Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness [J].
Bech-Hansen, NT ;
Naylor, MJ ;
Maybaum, TA ;
Sparkes, RL ;
Koop, B ;
Birch, DG ;
Bergen, AAB ;
Prinsen, CFM ;
Polomeno, RC ;
Gal, A ;
Drack, AV ;
Musarella, MA ;
Jacobson, SG ;
Young, RSL ;
Weleber, RG .
NATURE GENETICS, 2000, 26 (03) :319-323
[8]   Loss-of-function mutations in a calcium-channel α1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness [J].
Bech-Hansen, NT ;
Naylor, MJ ;
Maybaum, TA ;
Pearce, WG ;
Koop, B ;
Fishman, GA ;
Mets, M ;
Musarella, MA ;
Boycott, KM .
NATURE GENETICS, 1998, 19 (03) :264-267
[9]   Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F [J].
Boycott, KM ;
Pearce, WG ;
Bech-Hansen, NT .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2000, 35 (04) :204-213
[10]  
CARR R. E., 1966, INVEST OPHTHALMOL, V5, P497